Chief Executive Officer: Steve Perrin, Ph.D.
Steve Perrin, Ph.D., joined the ALS Therapy Development Institute in 2007. Under his leadership as CEO,
ALS TDI has assembled a world class scientific team and created an innovative business model bridging
philanthropic investments in early stages of drug development with for-profit biotechnology companies
to manage clinical translation.
Video Coming Soon